Can RNA Expression Profiles Help Predict Risk of Recurrence in High-intermediate Risk Endometrial Cancer Patients?

被引：0
|
作者：
Goldsberry, W. [1 ]
Kamal, M. Z. [1 ]
Davis, A. M. [1 ]
Londono, A. I. [1 ]
Foxall, M. E. [1 ]
Katre, A. A. [1 ]
Roane, B. M. [1 ]
Martinez, A. [1 ]
Arend, R. C. [1 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 158卷 / 01期
关键词：
D O I：
10.1016/j.ygyno.2020.04.022
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
21
引用
收藏
页码：E10 / E10
页数：1
相关论文
共 50 条
  • [31] Hypofractionated IGRT in high-intermediate and high/very-high risk prostate cancer patients
    Di Muzio, N. G.
    Deantoni, C. L.
    Brombin, C.
    Cozzarini, C.
    Broggi, S.
    Mangili, P.
    Di Serio, M. S.
    Dell'Oca, I.
    Chiara, A.
    Calandrino, R.
    Fiorino, C.
    Fodor, A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S857 - S857
  • [32] Clinicopathologic evaluation of CTNNB1 gene mutations in high-intermediate risk endometrial cancer.
    Haag, Jennifer G.
    Wolsky, Rebecca J.
    Moroney, Marisa R.
    Sheren, Jamie
    Sheeder, Jeanelle
    Bitler, Benjamin G.
    Corr, Bradley R.
    CLINICAL CANCER RESEARCH, 2021, 27 (03)
  • [33] Nodal staging in high and high-intermediate risk endometrial cancer surgery: Which role in the molecular classification era?
    Massobrio, Roberta
    Novara, Lorenzo
    Mancarella, Matteo
    Pace, Luca
    Giorgi, Margherita
    Pascotto, Maria
    Campigotto, Beatrice
    Fuso, Luca
    Sgro, Luca Giuseppe
    Bounous, Valentina Elisabetta
    Ferrero, Annamaria
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2024, 53 (07)
  • [34] IDENTIFICATION OF MICRO-RNA EXPRESSION PROFILES RELATED TO RECURRENCE IN WOMEN WITH ESMO LOW RISK ENDOMETRIAL CANCER
    Canlorbe, G.
    Cyril, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1062 - 1062
  • [35] IDENTIFICATION OF MICRO-RNA EXPRESSION PROFILES RELATED TO RECURRENCE IN WOMEN WITH ESMO LOW RISK ENDOMETRIAL CANCER
    Canlorbe, G.
    Cyril, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 184 - 184
  • [36] Does thorough surgical staging eliminate the need for radiation therapy in high-intermediate risk endometrial cancer?
    Tierney, B. J.
    Larsen, G.
    Simons, M.
    Crotzer, D.
    Morris, P.
    Cloven, N.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S71 - S72
  • [37] Clinical relevance of high-intermediate risk endometrial cancer according to European risk classification (vol 30, pg 1528, 2020)
    Rychlik, A.
    Zapardiel, I
    Baquedano, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (11) : 1852 - 1852
  • [38] Recognizing Patients With High-Intermediate Risk Acute Pulmonary Embolism
    Katyal, Anup
    Seedat, Zed
    Ponzillo, John
    ANNALS OF EMERGENCY MEDICINE, 2024, 83 (02) : 181 - 182
  • [39] Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer
    Zusterzeel, P. L. M.
    Bekkers, R. L. M.
    Hendriks, J. C. M.
    Neesham, D. N.
    Rome, R. M.
    Quinn, M. A.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2008, 87 (02) : 240 - 246
  • [40] MMR deficiency identifies patients with high intermediate risk (HIR) endometrial cancer at highest risk of recurrence: A prognostic and possible predictive biomarker for HIR endometrial cancer
    Haag, J.
    Cosgrove, C. M.
    Cohn, D. E.
    Suarez, A.
    Goodfellow, P. J.
    Backes, F. J.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 180 - 180
12345